Search details
1.
Development of a 3D functional assay and identification of biomarkers, predictive for response of high-grade serous ovarian cancer (HGSOC) patients to poly-ADP ribose polymerase inhibitors (PARPis): targeted therapy.
J Transl Med
; 18(1): 439, 2020 11 19.
Article
in English
| MEDLINE | ID: mdl-33213473
2.
LY75 Ablation Mediates Mesenchymal-Epithelial Transition (MET) in Epithelial Ovarian Cancer (EOC) Cells Associated with DNA Methylation Alterations and Suppression of the Wnt/ß-Catenin Pathway.
Int J Mol Sci
; 21(5)2020 Mar 07.
Article
in English
| MEDLINE | ID: mdl-32156068
3.
The polypeptide GALNT6 Displays Redundant Functions upon Suppression of its Closest Homolog GALNT3 in Mediating Aberrant O-Glycosylation, Associated with Ovarian Cancer Progression.
Int J Mol Sci
; 20(9)2019 May 08.
Article
in English
| MEDLINE | ID: mdl-31071912
4.
Global methylation profiling in serous ovarian cancer is indicative for distinct aberrant DNA methylation signatures associated with tumor aggressiveness and disease progression.
Gynecol Oncol
; 128(2): 356-63, 2013 Feb.
Article
in English
| MEDLINE | ID: mdl-23219462
5.
A novel genome-based approach correlates TMPRSS3 overexpression in ovarian cancer with DNA hypomethylation.
Gynecol Oncol
; 125(3): 720-6, 2012 Jun.
Article
in English
| MEDLINE | ID: mdl-22446619
6.
Molecular determinants of LPS-induced acute renal inflammation: Implication of the kinin B1 receptor.
Biochem Biophys Res Commun
; 386(2): 407-12, 2009 Aug 21.
Article
in English
| MEDLINE | ID: mdl-19538936
7.
The strand separation and nuclease activities associated with YB-1 are dispensable for cisplatin resistance but overexpression of YB-1 in MCF7 and MDA-MB-231 breast tumor cells generates several chemoresistance signatures.
Int J Biochem Cell Biol
; 40(11): 2492-507, 2008.
Article
in English
| MEDLINE | ID: mdl-18571458
8.
Global gene expression analysis of early response to chemotherapy treatment in ovarian cancer spheroids.
BMC Genomics
; 9: 99, 2008 Feb 26.
Article
in English
| MEDLINE | ID: mdl-18302766
9.
Immunohistochemical analysis of possible chemoresistance markers identified by micro-arrays on serous ovarian carcinomas.
Mod Pathol
; 21(8): 1002-10, 2008 Aug.
Article
in English
| MEDLINE | ID: mdl-18500265
10.
Altered expression of different GalNActransferases is associated with disease progression and poor prognosis in women with high-grade serous ovarian cancer.
Int J Oncol
; 51(6): 1887-1897, 2017 Dec.
Article
in English
| MEDLINE | ID: mdl-29039611
11.
Hic-5 regulates epithelial to mesenchymal transition in ovarian cancer cells in a TGFß1-independent manner.
Oncotarget
; 8(47): 82506-82530, 2017 Oct 10.
Article
in English
| MEDLINE | ID: mdl-29137281
12.
Suppression of the grainyhead transcription factor 2 gene (GRHL2) inhibits the proliferation, migration, invasion and mediates cell cycle arrest of ovarian cancer cells.
Cell Cycle
; 16(7): 693-706, 2017 Apr 03.
Article
in English
| MEDLINE | ID: mdl-28278050
13.
Systems biology combining human- and animal-data miRNA and mRNA data identifies new targets in ureteropelvic junction obstruction.
BMC Syst Biol
; 11(1): 31, 2017 03 01.
Article
in English
| MEDLINE | ID: mdl-28249581
14.
Gene expression patterns of chemoresistant and chemosensitive serous epithelial ovarian tumors with possible predictive value in response to initial chemotherapy.
Int J Oncol
; 29(4): 919-33, 2006 Oct.
Article
in English
| MEDLINE | ID: mdl-16964388
15.
Gene expression profiling of paired ovarian tumors obtained prior to and following adjuvant chemotherapy: molecular signatures of chemoresistant tumors.
Int J Oncol
; 29(1): 5-24, 2006 Jul.
Article
in English
| MEDLINE | ID: mdl-16773180
16.
In vivo DNase I-mediated footprinting analysis along the human bradykinin B1 receptor (BDKRB1) gene promoter: evidence for cell-specific regulation.
Biochem J
; 389(Pt 1): 37-46, 2005 Jul 01.
Article
in English
| MEDLINE | ID: mdl-15705059
17.
The mannose receptor LY75 (DEC205/CD205) modulates cellular phenotype and metastatic potential of ovarian cancer cells.
Oncotarget
; 7(12): 14125-42, 2016 Mar 22.
Article
in English
| MEDLINE | ID: mdl-26871602
18.
BCAT1 expression associates with ovarian cancer progression: possible implications in altered disease metabolism.
Oncotarget
; 6(31): 31522-43, 2015 Oct 13.
Article
in English
| MEDLINE | ID: mdl-26372729
19.
Role of the polypeptide N-acetylgalactosaminyltransferase 3 in ovarian cancer progression: possible implications in abnormal mucin O-glycosylation.
Oncotarget
; 5(2): 544-60, 2014 Jan 30.
Article
in English
| MEDLINE | ID: mdl-24504219
20.
The RUNX1 transcription factor is expressed in serous epithelial ovarian carcinoma and contributes to cell proliferation, migration and invasion.
Cell Cycle
; 12(6): 972-86, 2013 Mar 15.
Article
in English
| MEDLINE | ID: mdl-23442798